Name
Osaühing Eesti Diabeedikeskus
Registry code
10886393
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
12.08.2002 (22)
Financial year
01.01-31.12
Capital
2 540.00 €
Activity
86221 - Provision of specialised medical treatment
1 007 916 €
66 911 €
7%
2 129 €
(estimate is approximate)
101 072 €
9
Submitted
No tax arrears
66%
34%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Omanikukonto: MARJU PAST 27.02.1963 (61) | 100% - 2 540.00 EUR | Board member | Direct ownership | |
| Ermitex Grupp OÜ 10205223 | - | - | - | Founder |
| 2019 03.07.2020 | 2020 28.06.2021 | 2021 29.06.2022 | 2022 30.06.2023 | 2023 19.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 645 645 € | 766 724 € | 878 237 € | 851 862 € | 1 007 916 € |
| Net profit (loss) for the period | 42 434 € | 71 543 € | 32 664 € | 34 945 € | 66 911 € |
| Profit Margin | 7% | 9% | 4% | 4% | 7% |
| Current Assets | 150 996 € | 146 071 € | 130 683 € | 132 920 € | 196 095 € |
| Fixed Assets | 0 € | 0 € | 0 € | 0 € | 0 € |
| Total Assets | 150 996 € | 146 071 € | 130 683 € | 132 920 € | 196 095 € |
| Current Liabilities | 65 987 € | 49 519 € | 71 467 € | 58 759 € | 95 023 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 85 009 € | 96 552 € | 59 216 € | 74 161 € | 101 072 € |
| Employees | 7 | 8 | 9 | 9 | 9 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 28 790.52 € | 30 699.49 € | 10 |
| 2023 Q4 | - | 38 017.55 € | 33 467.34 € | 10 |
| 2023 Q3 | - | 28 812.68 € | 30 759.4 € | 10 |
| 2023 Q2 | - | 27 711.28 € | 29 564.56 € | 10 |
| 2023 Q1 | - | 28 911.48 € | 29 085.96 € | 11 |
| 2022 Q4 | - | 28 603.97 € | 28 881.91 € | 11 |
| 2022 Q3 | - | 27 654.54 € | 29 963.56 € | 11 |
| 2022 Q2 | - | 26 062.44 € | 28 243.75 € | 11 |
| 2022 Q1 | - | 27 244.1 € | 29 505.29 € | 11 |
| 2021 Q4 | - | 31 349.72 € | 25 814.24 € | 11 |
| 2021 Q3 | - | 34 060.77 € | 29 684.65 € | 11 |
| 2021 Q2 | - | 24 900.74 € | 27 048.78 € | 11 |
| 2021 Q1 | - | 26 438.79 € | 23 299.71 € | 11 |
| 2020 Q4 | - | 20 148.01 € | 21 905.86 € | 10 |
| 2020 Q3 | - | 28 969.34 € | 22 387.41 € | 10 |
| 2020 Q2 | - | 8 372.89 € | 9 111.24 € | 10 |
| 2020 Q1 | - | 17 666.94 € | 19 200.04 € | 10 |
